Sean Grant
2022
In 2022, Sean Grant earned a total compensation of $2.5M as Chief Financial Officer at Vera Therapeutics, a 19% increase compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $168,000 |
|---|---|
| Option Awards | $1,258,893 |
| Salary | $417,500 |
| Stock Awards | $627,750 |
| Total | $2,472,143 |
Grant received $1.3M in option awards, accounting for 51% of the total pay in 2022.
Grant also received $168K in non-equity incentive plan, $417.5K in salary and $627.8K in stock awards.
Rankings
In 2022, Sean Grant's compensation ranked 1,466th out of 5,625 executives tracked by ExecPay. In other words, Grant earned more than 73.9% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 1,466 out of 5,625 | 74th |
Division Manufacturing | 732 out of 3,053 | 76th |
Major group Chemicals And Allied Products | 283 out of 1,380 | 80th |
Industry group Drugs | 262 out of 1,281 | 80th |
Industry Pharmaceutical Preparations | 186 out of 927 | 80th |
Source: SEC filing on March 30, 2023.
Grant's colleagues
We found two more compensation records of executives who worked with Sean Grant at Vera Therapeutics in 2022.